|
|
 |
|
Viewing report
|
|
|
|
ePrescribing: Infrastructure and Impact on the Healthcare Markets in the US and EU
Datamonitor, March 2007, Pages: 47
Technology has been used to either inform or expedite the prescribing process in most modern healthcare systems for over two decades. Recently, market forces - including greater regulatory intervention, increased investment from stakeholders and decreased resistance from end-users - have begun to converge to set the stage for widespread adoption of truly integrated ePrescribing solutions.
Scope of this title:
Insight into the different approaches taken towards adoption of ePrescribing in the US and the EU Identification of current drivers of adoption and why they are important to the success of ePrescribing long-term Analysis of physicians and consumers views on ePrescribing and how they are affecting the rate of adoption in the US and EU Recommendations for pharmaceutical industry as to how to retain a share-of-voice in adoption, particularly as regards designing functional standards
Highlights of this title:
One of the greatest challenges facing ePrescribing has been finding a balance between the wants and needs of industry and end-users. Several stakeholders have been vying for influence over the design and implementation of ePrescribing systems. While this has served to move the market forward considerable conflicts of interest have also emerged. The attitude of the physician towards ePrescribing is the most important consideration for stakeholders because it is the point at which adoption either stalls or moves forward. Historically, physicians have been offered a variety of reasons and incentives to adopt ePrescribing, with varying degrees of success. It is the pharmaceutical industrys responsibility to ensure that decisions made at the point of care are not unduly controlled by other stakeholders, such as disruptive messaging meant to influence a physician to continuously second-guess specific prescribing decisions, or inequitable screen displays, which give preference to certain treatments.
Reasons to order your copy:
Identify the dangers of the traditional paper-based prescribing model and how electronic prescribing can improve patient safety and compliance Understand the importance of developing electronic medical records in parallel with ePrescribing initiatives Assess opportunities for pharmaceutical companies to maintain a share-of-voice during the prescribing process
Customers who bought this item also bought
ePrescribing Technologies: Finding a role for Pharma
Electronic Prescribing: Maintaining Leverage in the Future Prescribing Process
The Evolving ePrescribing Market Players: Strategies for Successful Partnerships
eHealth for the Pharmaceutical Industry: What Companies Need to Know about Trends in Physicians and Consumers Use of the Internet
U.S. e-Prescribing Markets among Ambulatory Care Providers
Influencing Physician Prescribing: Online Strategies
The Changing Patient-Physician Relationship Part 2: the Physicians Perspective
Pharmaceutical Pricing, Reimbursement, and Prescribing News in the Second Quarter of 2007
The ehealth Market In The UK: Assessing The Online Needs Of Physicians And Consumers
Maximizing Prescribing Opportunities: Capitalizing on Primary and Secondary Care
Maximizing Prescribing Opportunities: Capitalizing on Primary and Secondary Care
eHealth Solutions for Pharma: Strategies for Salesforces, Marketing, Patient Compliance and Clinical Trials
|
|
|
|
